CheckMate-214 trial results show longer treatment-free survival with immunotherapy

Cancer. 2022 Mar 15;128(6):1156. doi: 10.1002/cncr.34139.
No abstract available

Publication types

  • News

MeSH terms

  • Clinical Trials as Topic*
  • Disease-Free Survival
  • Humans
  • Immunotherapy*
  • Treatment Outcome